1st Detect Awarded EU Patent for Chemical Detection Technology
Tuesday, March 6th, 2012
AUSTIN, Texas, March 6, 2012 (CRWENewswire) — 1st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that the European Patent Office (EPO) has issued a key patent for the company’s unique method to drive a mass spectrometer ion trap used for chemical analysis and detection.
“We are extremely pleased that the EPO has issued this patent, in conjunction with its USPTO counterpart US 7,973,227 issued on 05 Jul 2011. This patent is an important component of our intellectual property portfolio as it covers our unique ion trap technology.” said Thomas B Pickens III, Chairman of 1st Detect and CEO of Astrotech. “Europe is a very important market for our technology and this patent both demonstrates and protects the progress we have made in the development of the 1st Detect Miniature Mass Spectrometer.”
The patent, entitled “Driving a Mass Spectrometer Ion Trap or Mass Filter,” represents a key technological advantage for 1st Detect to optimize the operation of an ion trap using compact and efficient circuitry.
“The technology protected by this patent supports our objective to offer the most affordable, high performance mass spectrometer for both laboratory and field applications.” added David Rafferty, the inventor of the Patent (EU 2 301 061) and President of the Company.
1st Detect Corporation has developed an instrument that revolutionizes the chemical detection and analysis market by delivering lab performance mass spectrometry in a small, affordable and easily portable package. The 1st Detect mini mass spectrometer’s broad capabilities make it an ideal tool for a variety of applications in the research, security, industrial, process flow and healthcare markets; and is capable of detecting a wide variety of chemicals including residues and vapors from explosives, chemical warfare agents, toxic chemicals, food and beverage contaminants and pollution products.
About 1st Detect Corp.
1st Detect Corporation was formed by Astrotech Corporation (Nasdaq:ASTC) to develop and commercialize miniature-mass spectrometer technology first developed under an agreement with NASA for use on the International Space Station (ISS). 1st Detect offers what we believe is a breakthrough mini-mass spectrometry technology that fills an unmet need by being highly accurate, rapid, lightweight, durable and cost-effective. For more information on 1st Detect Corporation, please visit www.1stdetect.com
About Astrotech Corporation
Astrotech is one of the first space commerce companies and remains a strong entrepreneurial force in the aerospace industry. We are leaders in identifying, developing and marketing space technology for commercial use. Our Astrotech Space Operations business unit serves our government and commercial satellite and spacecraft customers with pre-launch services on the eastern and western range. 1st Detect Corporation is developing what we believe is a breakthrough miniature mass spectrometer, while Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development.
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.
Contact:
James Wylde
Vice President, Business Development
1st Detect Corporation
972-617-9939
jwylde@1stdetect.com
Source: 1st Detect Corporation
********************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
